1. Home
  2. ESCA vs GANX Comparison

ESCA vs GANX Comparison

Compare ESCA & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Escalade Incorporated

ESCA

Escalade Incorporated

HOLD

Current Price

$14.61

Market Cap

184.7M

ML Signal

HOLD

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$1.80

Market Cap

159.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESCA
GANX
Founded
1922
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
184.7M
159.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ESCA
GANX
Price
$14.61
$1.80
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$8.00
AVG Volume (30 Days)
17.6K
865.6K
Earning Date
02-25-2026
03-26-2026
Dividend Yield
4.19%
N/A
EPS Growth
N/A
N/A
EPS
0.92
N/A
Revenue
$241,540,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.00
N/A
P/E Ratio
$15.56
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.41
$1.41
52 Week High
$16.99
$4.34

Technical Indicators

Market Signals
Indicator
ESCA
GANX
Relative Strength Index (RSI) 64.77 32.04
Support Level $14.50 $1.61
Resistance Level $14.96 $2.07
Average True Range (ATR) 0.37 0.15
MACD 0.02 0.00
Stochastic Oscillator 87.39 5.66

Price Performance

Historical Comparison
ESCA
GANX

About ESCA Escalade Incorporated

Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are North America, Europe and others out of which a substantial part of the revenue is generated from North America region.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: